RESUMO
We address ethical, legal, and practical issues related to adolescent self-consent for human papillomavirus (HPV) vaccination. HPV vaccination coverage continues to lag well behind the national goal of 80% series completion. Structural and behavioral interventions have improved vaccination rates, but attitudinal, behavioral, and access barriers remain. A potential approach for increasing access and improving vaccination coverage would be to permit adolescents to consent to HPV vaccination for themselves. We argue that adolescent self-consent is ethical, but that there are legal hurdles to be overcome in many states. In jurisdictions where self-consent is legal, there can still be barriers due to lack of awareness of the policy among healthcare providers and adolescents. Other barriers to implementation of self-consent include resistance from antivaccine and parent rights activists, reluctance of providers to agree to vaccinate even when self-consent is legally supported, and threats to confidentiality. Confidentiality can be undermined when an adolescent's self-consented HPV vaccination appears in an explanation of benefits communication sent to a parent or if a parent accesses an adolescent's vaccination record via state immunization information systems. In the context of the COVID-19 pandemic, which has led to a substantial drop in HPV vaccination, there may be even more reason to consider self-consent. The atmosphere of uncertainty and distrust surrounding future COVID-19 vaccines underscores the need for any vaccine policy change to be pursued with clear communication and consistent with ethical principles.
Assuntos
Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Infecções por Papillomavirus/prevenção & controle , Vacinas contra Papillomavirus , Adolescente , Fatores Etários , COVID-19/prevenção & controle , Vacinas contra COVID-19 , Humanos , Competência Mental/legislação & jurisprudência , Competência Mental/psicologia , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Estados UnidosAssuntos
Doença de Hodgkin/história , Consentimento Informado por Menores/história , Consentimento dos Pais/história , Participação do Paciente/história , Recusa do Paciente ao Tratamento/história , Adolescente , Connecticut , Dissidências e Disputas/história , Dissidências e Disputas/legislação & jurisprudência , Feminino , História do Século XXI , Doença de Hodgkin/terapia , Humanos , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Consentimento dos Pais/ética , Consentimento dos Pais/legislação & jurisprudência , Participação do Paciente/legislação & jurisprudência , Relações Profissional-Família/ética , Relações Profissional-Paciente/ética , Recusa do Paciente ao Tratamento/ética , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Adulto JovemRESUMO
Cases of adolescents in organ failure who refuse solid organ transplant are not common, but several have been discussed in the media in the United States and the United Kingdom. Using the framework developed by Buchanan and Brock for surrogate decision-making, I examine what role the adolescent should morally play when deciding about therapy for life-threatening conditions. I argue that the greater the efficacy of treatment, the less voice the adolescent (and the parent) should have. I then consider how refusals of highly effective transplant cases are similar to and different from refusals of other lifesaving therapies (eg, chemotherapy for leukemia), which is more commonly discussed in the media and medical literature. I examine whether organ scarcity and the need for lifelong immunosuppression justify differences in whether the state intervenes when an adolescent and his or her parents refuse a transplant. I argue that the state, as parens patriae, has an obligation to provide the social supports needed for a successful transplant and follow-up treatment plan, although family refusals may be permissible when the transplant is experimental or of low efficacy because of comorbidities or other factors. I conclude by discussing the need to limit media coverage of pediatric treatment refusals.
Assuntos
Temas Bioéticos , Meios de Comunicação de Massa/ética , Transplante de Órgãos/ética , Consentimento dos Pais/ética , Recusa do Paciente ao Tratamento/ética , Adolescente , Família , Feminino , Humanos , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Masculino , Transplante de Órgãos/legislação & jurisprudência , Consentimento dos Pais/legislação & jurisprudência , Participação do Paciente , Patient Self-Determination Act , Ética Baseada em Princípios , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Gêmeos Monozigóticos , Reino Unido , Estados UnidosRESUMO
It has been ten years since the case of Hannah Jones-the 12-year-old girl who was permitted to refuse a potentially life-saving heart transplant. In the past decade, there has been some progress within law and policy in respect of children's participatory rights (UNCRC-Article 12), and a greater understanding of family-centred decision-making. However, the courts still largely maintain their traditional reluctance to find children Gillick competent to refuse medical treatment. In this article, I revisit Hannah's case through the narrative account provided by Hannah and her mother, to ascertain what lessons can be learnt. I use an Ethics of Care framework specially developed for children in mid-childhood, such as Hannah, to argue for more a creative and holistic approach to child decision-making in healthcare. I conclude that using traditional paradigms is untenable in the context of palliative care and at the end of life, and that the law should be able to accommodate greater, and even determinative, participation of children who are facing their own deaths.
Assuntos
Tomada de Decisões , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Competência Mental/legislação & jurisprudência , Doente Terminal , Recusa do Paciente ao Tratamento/ética , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Criança , Feminino , Guias como Assunto , Humanos , Cuidados Paliativos/ética , Pais , Autonomia Pessoal , Assistência Terminal/ética , Reino UnidoRESUMO
Thirty years ago, the transgender child would have made no sense to the general public, nor to young people. Today, children and adolescents declare themselves transgender, the National Health Service diagnoses 'gender dysphoria', and laws and policy are developed which uphold young people's 'choice' to transition and to authorize stages at which medical intervention is permissible and desirable. The figure of the 'transgender child' presumed by medicine and law is not a naturally occurring category of person external to medical diagnosis and legal protection. Medicine and law construct the 'transgender child' rather than that the 'transgender child' exists independently of medico-legal discourse. The ethical issue of whether the child and young person can 'consent' to social and medical transition goes beyond legal assessment of whether a person under16 years has the mental capacity to consent, understand to what s/he is consenting, and can express independent wishes. It shifts to examination of the recent making of 'the transgender child' through the complex of power/knowledge/ethics of medicine and the law of which the child can have no knowledge but within which its own desires are both constrained and incited.
Assuntos
Saúde do Adolescente/tendências , Saúde da Criança/tendências , Disforia de Gênero/diagnóstico , Identidade de Gênero , Política de Saúde/legislação & jurisprudência , Política de Saúde/tendências , Pessoas Transgênero , Adolescente , Adulto , Criança , Tomada de Decisões , Feminino , Disforia de Gênero/terapia , Hormônios/administração & dosagem , Direitos Humanos , Humanos , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Masculino , Programas Nacionais de Saúde , Pessoalidade , Procedimentos de Readequação Sexual/ética , Reino UnidoRESUMO
Guidelines are provided for doctors where a parent or guardian tries to override an otherwise legally competent child's consent to a surgical operation by refusing to provide the assistance required by the Children's Act. Consideration is given to whether an otherwise legally competent child is competent to consent to a surgical operation when this can be overridden by their parent or guardian, and the legal position regarding informed consent by a child to the surgical termination of her pregnancy.
Assuntos
Consentimento Informado por Menores/legislação & jurisprudência , Consentimento dos Pais/legislação & jurisprudência , Procedimentos Cirúrgicos Operatórios/legislação & jurisprudência , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Aborto Legal/legislação & jurisprudência , Adolescente , Criança , Feminino , Humanos , GravidezRESUMO
More and more children, and even more so adolescents, undergo procedures pertaining to the category of aesthetic surgery and mainly aiming to improve the patient's physical appearance. There is a broad spectrum of possible operations ranging from purely cosmetic procedures to operations with a medical indication.
Assuntos
Menores de Idade/legislação & jurisprudência , Procedimentos de Cirurgia Plástica/ética , Procedimentos de Cirurgia Plástica/legislação & jurisprudência , Adolescente , Pré-Escolar , Orelha Externa/anormalidades , Orelha Externa/cirurgia , Ética Médica , Alemanha , Humanos , Consentimento Informado por Menores/legislação & jurisprudência , Consentimento Informado por Menores/psicologia , Cobertura do Seguro/legislação & jurisprudência , Menores de Idade/psicologia , Programas Nacionais de Saúde/legislação & jurisprudência , Consentimento dos Pais/legislação & jurisprudência , Consentimento dos Pais/psicologia , Autonomia Pessoal , Procedimentos de Cirurgia Plástica/psicologiaRESUMO
BACKGROUND: Italian law no. 86 of 5 June 2012, which establishes a set of rules on the matter of breast implants, came into effect in July 2012. The law is at the center of a widespread and animated cultural debate that in recent years has been taking place in Italy. DISCUSSION: The fundamental prohibition imposed by the law concerns the age limit. Breast implants for exclusively aesthetic purposes are allowed only if the legal age (18 years) has been reached. This prohibition does not apply in cases of severe congenital malformations certified by a physician operating within the National Health Service or by a public health care institution. The legal imposition of an age limit raises a number of perplexities: one at a bioethical level and one that is strictly juridical. In fact, it is impossible to deal with this issue unless the wider debate concerning the self-determination and autonomy of underage patients in biomedical matters is considered. It appears, then, that the issue is again exclusively related to the peculiarity of cosmetic surgery, which when aimed at correcting "only" the pathologic experiences of self-image, does not acquire the dignity of therapy. If, however, the improvement of self-image serves to achieve a better psycho-emotional balance and favors the development of social relations undermined by evident physical defects, age restrictions can be disregarded. The authors believe the real risk is that the law imposed by the Italian state is based on assumptions and preformed value judgments. Furthermore, in the understanding of needs, legislation often is biased toward objective biophysical problems without attaching due importance to subjective psychological and social problems. While acknowledging the seriousness of the issue, the authors do not agree with the legislature's rigidity. However, plastic surgeons must form a plan for addressing the concerns about breast implants and evaluating whether they are appropriate for adolescents, taking into account the unique psychological and developmental considerations of adolescent cosmetic surgery patients. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Implante Mamário/ética , Implante Mamário/legislação & jurisprudência , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Adolescente , Implante Mamário/psicologia , Humanos , ItáliaAssuntos
Consentimento Informado por Menores/legislação & jurisprudência , Competência Mental/legislação & jurisprudência , Relações Pais-Filho/legislação & jurisprudência , Adolescente , Adulto , Fatores Etários , Neoplasias Cerebelares/terapia , Criança , Tomada de Decisões , Feminino , Humanos , Masculino , Meduloblastoma/terapia , Reino UnidoRESUMO
As cancer treatment becomes more and more effective, there is greater life expectancy for cancer patients. Because of this, depending upon the modality used in the treatment of cancer, the matter of infertility emerges before us as an issue of increasing significance. Sperm cryopreservation and embryo cryopreservation are well-established methods of fertility preservation (FP). Besides these validated FP options, some FP techniques such as oocyte cryopreservation and ovarian tissue cryopreservation are as yet in the experimental stage. FP medicine has experienced some rapid developments in recent years. The advances in this branch of medicine, however, have also brought about new ethical, medical and legal issues. Some of these include problems with obtaining the informed consent of minors, issues that arise because of the experimental nature of some methods, financial problems and the accessibility of FP methods, and the question of what happens to gametes when a patient dies. This review seeks to discuss, in the light of current literature, some ethical and technical issues and risks related to the implementation of FP methods in women with cancer.
Assuntos
Preservação da Fertilidade/métodos , Infertilidade Feminina/complicações , Neoplasias/complicações , Feminino , Preservação da Fertilidade/ética , Preservação da Fertilidade/legislação & jurisprudência , Preservação da Fertilidade/psicologia , Humanos , Infertilidade Feminina/etiologia , Infertilidade Feminina/psicologia , Infertilidade Feminina/terapia , Consentimento Livre e Esclarecido/ética , Consentimento Livre e Esclarecido/legislação & jurisprudência , Consentimento Livre e Esclarecido/psicologia , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Consentimento Informado por Menores/psicologia , Masculino , Neoplasias/diagnóstico , Neoplasias/psicologia , Neoplasias/terapia , Prognóstico , Terapias em Estudo/efeitos adversos , Terapias em Estudo/éticaAssuntos
Serviços Médicos de Emergência/legislação & jurisprudência , Consentimento Informado por Menores/legislação & jurisprudência , Recusa do Paciente ao Tratamento/legislação & jurisprudência , Adolescente , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Transfusão de Sangue/legislação & jurisprudência , Terapias Complementares/legislação & jurisprudência , Cetoacidose Diabética/terapia , Feminino , Doença de Hodgkin/tratamento farmacológico , Homicídio/legislação & jurisprudência , Humanos , Testemunhas de Jeová , Tutores Legais/legislação & jurisprudência , Leucemia/terapia , Masculino , Consentimento dos Pais/legislação & jurisprudência , Religião e Medicina , Estados UnidosRESUMO
In this article we examine decision-making about complementary and alternative medicine use when the patient is an adolescent. A case scenario describes patient-parent conflict when a 14-year-old boy who was diagnosed with ulcerative colitis that has continued to progress even with medication refuses recommended surgery despite his physician's and parents' support for that option; he prefers homeopathy instead. We address (1) who has decision-making authority about treatment for young people, (2) how to determine if a young person can consent to or refuse treatment, (3) special considerations when counseling and treating adolescents (whether they can decide about treatment for themselves), and (4) parent-child conflicts about treatment. In addition, we suggest ways that health care providers can foster a trusting relationship with patients and parents.
Assuntos
Terapias Complementares , Tomada de Decisões , Consentimento Informado por Menores , Competência Mental , Participação do Paciente , Preferência do Paciente , Adolescente , Canadá , Criança , Proteção da Criança/ética , Proteção da Criança/legislação & jurisprudência , Colite Ulcerativa/terapia , Tomada de Decisões/ética , Ética Médica , Humanos , Consentimento Informado por Menores/ética , Consentimento Informado por Menores/legislação & jurisprudência , Masculino , Relações Pais-Filho , Relações Médico-Paciente , Recusa do Paciente ao Tratamento , Estados UnidosRESUMO
BACKGROUND: Public awareness and concern about cosmetic surgery on children is increasing. Nationally and internationally questions have been raised by the media and government bodies about the appropriateness of children undergoing cosmetic surgery. Considering the rates of cosmetic surgery in comparable Western societies, it seems likely that the number of physicians in Australia who will deal with a request for cosmetic surgery for a child will continue to increase. This is a sensitive issue and it is essential that physicians understand the professional and legal obligations that arise when cosmetic surgery is proposed for a child. OBJECTIVE: This article reviews the current professional and legal obligations that physicians have to competent and incompetent children for whom cosmetic surgery has been requested. DISCUSSION: A case study is used to highlight the factors that Australian primary care physicians must consider before referring and conducting cosmetic surgery on children.